|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||0.00 / 0.00|
The company reports good results, but we prefer to own pharmacy benefit managers.
S&P 500 stock buyback activity is at a multi-year high, and some S&P 500 stocks stand to see fourth quarter earnings get a boost from the buybacks.
Also, another holding announces a dividend, and we add to a bank position.
United BioSource Corporation (UBC), a wholly owned subsidiary of Medco Health Solutions, Inc.
I've put some money to work in the past two weeks -- now I want to book some big gains.
This PBM holding reiterated its plans to deliver solid long-term earnings growth.
I'll use the broad weakness today to increase my stake in this cheap growth holding.
Trading was focused Wednesday on the Medco November 60 calls, in which more than 3,600 were bought for 55 cents to 65 cents.
MedcoHealth Solutions Q3 2010 Earnings Call Transcript
We're exiting some positions on diminishing upside and making some buys on pullbacks.
Medco's third-quarter earnings rose 10.6% to $371.5 million, or 85 cents a share, as revenue jumped 10.3% and prescription volumes increased.
I'm paring down a couple positions and adding to some names that have more near-term catalysts.
Major companies tentatively scheduled to report quarterly results during week of 11/01/10
It was a mixed week that saw tech soar on earnings and financials plummet on more news of foreclosure fraud.
I have a 42% gain in this stock, so I'm taking some of those profits ahead of earnings.
I'm focused on building positions in names that offer outsized earnings and revenue growth relative to their peers.
I used the momentum of yet another strong week to take profits and build on some of my newer and smaller positions.
Cramer said this stock has looked good since he called it at $45.
Cramer tells what he goes through to pick stocks that provide maximum capital gains at minimal risks.
All three major market averages were up this week as investors continued to act on their voracious appetite for stocks.
I'm seeing some ups and downs in the portfolio due to company-specific actions, but overall movement is still net positive.
I'll lock in a gain in this consulting play after a 13.5% move in two weeks.
I'll add to a timber play and a pharmacy position, and I'm even more bullish on two holdings after recent news items.
Positive data, optimistic appraisals from management and continued momentum made this an encouraging week.
The group's fundamentals are favorable, and we're unfazed by one company's negative FDA news.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.